Abstract:The classic concept of the absence of lymphatic vessels in the central nervous system (CNS), suggesting the immune privilege of the brain in spite of its high metabolic rate, was predominant until recent times. On the other hand, this idea left questioned how cerebral interstitial fluid is cleared of waste products. It was generally thought that clearance depends on cerebrospinal fluid (CSF). Not long ago, an anatomically and functionally discrete paravascular space was revised to provide a pathway for the clearance of molecules drained within the interstitial space. According to this model, CSF enters the brain parenchyma along arterial paravascular spaces. Once mixed with interstitial fluid and solutes in a process mediated by aquaporin-4, CSF exits through the extracellular space along venous paravascular spaces, thus being removed from the brain. This process includes the participation of perivascular glial cells due to a sieving effect of their end-feet. Such draining space resembles the peripheral lymphatic system, therefore, the term "glymphatic" (glial-lymphatic) pathway has been coined. Specific studies focused on the potential role of the glymphatic pathway in healthy and pathological conditions, including neurodegenerative diseases. This mainly concerns Alzheimer's disease (AD), as well as hemorrhagic and ischemic neurovascular disorders; other acute degenerative processes, such as normal pressure hydrocephalus or traumatic brain injury are involved as well. Novel morphological and functional investigations also suggested alternative models to drain molecules through perivascular pathways, which enriched our insight of homeostatic processes within neural microenvironment. Under the light of these considerations, the present article aims to discuss recent findings and concepts on nervous lymphatic drainage and blood-brain barrier (BBB) in an attempt to understand how peripheral pathological conditions may be detrimental to the CNS, paving the way to neurodegeneration.

The Brain-Nose Interface: A Potential Cerebrospinal Fluid Clearance Site in Humans

The nasal lymphatic route of CSF outflow: implications for neurodegenerative disease diagnosis and monitoring

Cerebrospinal Fluid Dynamics: Uncovering Alternative Blood Vessel Clearance Mechanisms

Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases

Functional characterization of the dural sinuses as a neuroimmune interface

In vivo assessment of cerebrospinal fluid efflux to nasal mucosa in humans

Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative disease

Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases

Impaired Peri-Olfactory Cerebrospinal Fluid Clearance is Associated with Ageing, Cognitive Decline and Dyssomnia

Glymphatic System as a Gateway to Connect Neurodegeneration From Periphery to CNS

All Central Nervous System Neuro- and Vascular-Communication Channels Are Surrounded With Cerebrospinal Fluid

CNS and CNS Diseases in Relation to Their Immune System

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

The choroid plexus and its role in the pathogenesis of neurological infections

Understanding the nose-brain axis and its role in related diseases: A conceptual review

Cerebrospinal Fluid Efflux Through Dynamic Paracellular Pores on Venules As a Missing Piece of the Brain Drainage System

Dual role of the nasal microbiota in neurological diseases—An unignorable risk factor or a potential therapy carrier

From Nose to Brain: Understanding Transport Capacity and Transport Rate of Drugs

Ultrasonic cerebrospinal fluid clearance improves outcomes in hemorrhagic brain injury models

To Explore Nasal-Brain Lymphatic System for Brain-Targeted Drug Delivery and to Treat Neurodegenerative Diseases

The glymphatic system: implications for drugs for central nervous system diseases